1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Mean ADC values of all histologically proved entities of parotid gland tumors (n = 136)*
DiagnosisMean ADC values ± SD (95% CI) (× 10−3 mm2/s)
Pleomorphic adenoma (n = 43)2.09 ± 0.16 (2.03–2.14)
Warthin tumor (n = 32)0.89 ± 0.16 (0.82–0.96)
Myoepithelial adenoma (n = 6)1.86 ± 0.18 (1.83–1.91)
Lipoma (n = 3)0.62 ± 0.21 (0.54–0.76)
Basal cell adenoma (n = 1)1.23
Cystadenoma (n = 1)2.29
Inverted ductal papilloma (n = 1)1.99
Mucoepidermoid carcinoma (n = 16)1.05 ± 0.03 (0.97–1.14)
Salivary duct carcinoma (n = 11)1.10 ± 0.09 (0.89–1.31)
Acinic cell carcinoma (n = 10)0.79 ± 0.33 (0.68–0.88)
Basal cell adenocarcinoma (n = 9)0.96 ± 0.29 (0.71–1.12)
Adenoid cystic carcinoma (n = 1)0.87
Epithelial-myoepithelial carcinoma (n = 1)0.92
Carcinoma ex pleomorphic adenoma (n = 1)1.14
  • Note:—CI indicates confidence interval; ADC, apparent diffusion coefficient.
  • * In case of a single tumor, SD and 95% CI were not calculated.